agilon health inc. (NYSE:AGL) saw an upside of 3.42% to $24.21 after adding $0.8 on Tuesday. The 5-day average trading volume is 1,352,896 shares of the company’s common stock. It has gained $26.90 in the past week. An average of 999,644 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 802,940.
AGL’s 1-month performance is -26.27% or -$7.74 on its low of $20.81 reached on 10/12/21. The company’s shares have touched a 52-week low of $23.23 and high of $44.83. YTD, AGL has lost -24.48%. However, the current price is down -46.00%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Sep 14, 28 days have gone by since the last insider trading activity for agilon health inc. (AGL). Shaker Benjamin (Chief Markets Officer) most recently sold 73,018 shares at $28.98 per share on Sep 14. This transaction cost the insider $2,116,062. Director, Wulf John William, sold 15,342 shares at a price of $28.98 on Sep 14. Then, on Sep 14, CEO & President Sell Steven sold 100,000 shares at a price of $28.98 per share. This transaction amounted to $2,898,000.
agilon health inc. (AGL) has a trailing price-to-earnings (P/E) ratio of 23.70 for the broader industry and 32.26 for the sector.AGL stock has a beta of 0.00. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 7.02 while the price-to-book (PB) in the most recent quarter is 7.68.
agilon health inc.’s quick ratio for the period ended June 29 was 3.60, with the current ratio over the same period at 3.60 meaning that AGL stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.04, while the total debt to equity was 0.04The trailing 12-month EBITDA margin is -3.49%. The firm’s gross profit as reported stood at $94.15 million against revenue of $1.22 billion.
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Analysts expected AGL to announce -$0.05 per share in earnings in its latest quarter, but it posted -$0.79, representing a -1,480.00% surprise. EBITDA for the quarter stood at more than -$294.75 million. AGL stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 551.46 million, with total debt at $54.96 million. Shareholders hold equity totaling $390.88 million
Let’s look briefly at agilon health inc. (AGL) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 11 October was 25.03% to suggest the stock is trending oversold, with historical volatility in this time period at 47.36%.
The stock’s 5-day moving average is $25.09, reflecting a -7.87% or -$2.05 change from its current price. AGL is currently trading -22.90% above its 20-day SMA, -24.45% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -35.60%.
Stochastic %K and %D was 16.64% and 15.96% and the average true range (ATR) pointed at 1.66. The RSI (14) points at 26.22%, while the 14-day stochastic is at 40.25% with the period’s ATR at 1.59. The stock’s 9-day MACD Oscillator is pointing at -1.24 and -1.84 on the 14-day charts.
In the most recent analyst report for agilon health inc. (NYSE: AGL), SVB Leerink launched coverage with an Outperform rating. Analysts offering their rating for AGL stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate AGL as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 9 have offered a “buy” rating.
What is AGL’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $32.00 and a high of $46.00, with their median price target at $43.00. Looking at these predictions, the average price target given by analysts is for agilon health inc. (AGL) stock is $41.25.